SPOTLIGHT: Obesity scrips top 1 million in Britain

Use of obesity drugs in Britain is up eightfold in the last seven years, to more than 1 million prescriptions; the two most popular weight-loss drugs there are orlistat (sold as Xenical by Roche) and sibutramine (sold as Reductil by Abbott Laboratories). Report | Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.